Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 8:39 p.m.

    📋 Cerus Corporation (CERS) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 08:06:36

    Event Type: Clinical Trial Update

    Event Details:

    Cerus Corporation (CERS) Announces Clinical Trial Update Cerus Corporation (CERS) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: year, doses
    • Collaboration: CONCORD
    • Updated Timeline: full-year 2025
      • expected in mid-2026
      • expected in the second half of 2026

    🔬 Clinical Development Pipeline (Cerus Corporation):

    Product Type Development Stage Therapeutic Area Source
    MYNX CONTROLTM VENOUS Vascular Closure Device DEVICE Preclinical Venous Vascular Closure ClinicalTrials.gov
    INTERCEPT Blood System for RBCs DEVICE Phase PHASE2 Healthy Subjects ClinicalTrials.gov
    INTERCEPT Blood System for Red Blood Cells DEVICE Phase PHASE3 Anemia ClinicalTrials.gov
    Pathogen Reduced Cryoprecipitated Fibrinogen Complex BIOLOGICAL Preclinical Hypofibrinogenemia ClinicalTrials.gov
    Autologous apheresis Platelet Components, prepared with the INTERCEPT Blood System for Platelets. BIOLOGICAL Phase PHASE2 Healthy ClinicalTrials.gov
    INTERCEPT Platelets BIOLOGICAL Preclinical Chikungunya Virus ClinicalTrials.gov
    OrthoCor Advanced System DEVICE Approved Osteoarthritis, Knee ClinicalTrials.gov
    ultimaster DEVICE Preclinical Coronary Artery Disease ClinicalTrials.gov
    Pathogen-Reduced Cryoprecipitate BIOLOGICAL Phase PHASE4 Hypofibrinogenemia ClinicalTrials.gov
    Traditional Cryoprecipitate BIOLOGICAL Phase PHASE4 Hypofibrinogenemia ClinicalTrials.gov
    Bilateral Peripheral Intravenous Catheterisation DEVICE Approved Healthy ClinicalTrials.gov
    Conventional (Control) DEVICE Phase PHASE3 Anemia ClinicalTrials.gov
    Cryoprecipitated-Antihemophilic Factor BIOLOGICAL Preclinical Hypofibrinogenemia ClinicalTrials.gov
    Infusion of autologous radiolabeled RBCs OTHER Phase PHASE2 Healthy Subjects ClinicalTrials.gov
    Plain (Uncoated) Balloon Angioplasty (PTA) DEVICE Approved Peripheral Arterial Disease ClinicalTrials.gov
    SELUTION SLR™ 018 DEB DEVICE Approved Peripheral Arterial Disease ClinicalTrials.gov
    SELUTION SLR™ DEB 014 DEVICE Approved Peripheral Arterial Disease ClinicalTrials.gov
    PRECISE PRO Rx Nitinol Stent System DEVICE Preclinical Carotid Artery Stenosis ClinicalTrials.gov
    PCI with FDA approved "-limus" DES DEVICE Approved Coronary Artery Disease ClinicalTrials.gov
    PCI with SELUTION SLR DCB DEVICE Approved Coronary Artery Disease ClinicalTrials.gov
    Cypher Stent DEVICE Preclinical Cardiovascular Diseases ClinicalTrials.gov
    ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW) DEVICE Phase PHASE3 Carotid Artery Disease ClinicalTrials.gov
    -PRECISE Nitinol Stent System (5F, 5.5F and 6F) DEVICE Phase PHASE3 Carotid Artery Disease ClinicalTrials.gov
    CYPHERTM Sirolimus-Eluting Coronary Stent DEVICE Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    sirolimus-eluting stent DEVICE Phase PHASE3 Coronary Artery Disease ClinicalTrials.gov
    sirolimus coated Bx VELOCITY stent - slow release DEVICE Phase PHASE1 Coronary Artery Disease ClinicalTrials.gov
    sirolimus coated Bx VELOCITY stent - fast release DEVICE Phase PHASE1 Coronary Artery Disease ClinicalTrials.gov
    Cordis AAA Bilateral Device DEVICE Phase PHASE1 Abdominal Aortic Aneurysm ClinicalTrials.gov
    Taxus Paclitaxel-Eluting Stent DEVICE Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    Cypher Sirolimus-Eluting Stent DEVICE Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    Bx Cypher stent DEVICE Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    Sirolimus-coated Bx VELOCITY Stent DEVICE Phase PHASE1 Coronary Artery Disease ClinicalTrials.gov
    SIROLIMUS-ELUTING, HEPARIN-COATED CoCr BALLOON-EXPANDABLE STENT DEVICE Phase PHASE2 Coronary Artery Disease ClinicalTrials.gov
    PTCA OTHER Phase PHASE2 Coronary Artery Disease ClinicalTrials.gov
    Angioguard distal protection device DEVICE Phase PHASE2 Coronary Artery Disease ClinicalTrials.gov
    Sirolimus-Eluting BX Velocity Balloon-Expandable Stent DEVICE Phase PHASE1 Peripheral Vascular Diseases ClinicalTrials.gov
    Cypher DEVICE Phase PHASE2 Coronary Artery Disease ClinicalTrials.gov
    Cypher Select DEVICE Phase PHASE2 Coronary Artery Disease ClinicalTrials.gov
    balloon DEVICE Phase PHASE4 Superficial Femoral Artery Occlusions ClinicalTrials.gov
    stent DEVICE Phase PHASE4 Superficial Femoral Artery Occlusions ClinicalTrials.gov
    CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS) DEVICE Phase PHASE3 Coronary Artery Disease ClinicalTrials.gov
    angioplasty DEVICE Phase PHASE4 Arterial Occlusive Diseases ClinicalTrials.gov
    drug-eluting stent DEVICE Phase PHASE2 Coronary Artery Disease ClinicalTrials.gov
    drug eluting-stent DEVICE Phase PHASE2 Coronary Artery Disease ClinicalTrials.gov
    EES vs. SES DEVICE Approved Ischemic Heart Disease ClinicalTrials.gov
    kissing balloon inflation PROCEDURE Approved Ischemic Heart Disease ClinicalTrials.gov
    Luminexx Stent DEVICE Phase PHASE4 Arterial Occlusive Diseases ClinicalTrials.gov
    Smart Stent DEVICE Phase PHASE4 Arterial Occlusive Diseases ClinicalTrials.gov
    CYPHER® Bx Velocity™ stent (sirolimus-eluting) DEVICE Preclinical Coronary Stenosis ClinicalTrials.gov
    CYPHER Sirolimus-Eluting Coronary Stent DEVICE Phase PHASE3 Coronary Artery Disease ClinicalTrials.gov
    drug-eluting stent and balloon angioplasty DEVICE Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    uncoated Bx Velocity stent DEVICE Phase PHASE3 Coronary Artery Disease ClinicalTrials.gov
    bare-metal stent DEVICE Phase PHASE2 Peripheral Artery Disease ClinicalTrials.gov
    PRESILLION cobalt chromium stent DEVICE Phase PHASE3 Coronary Artery Disease ClinicalTrials.gov
    PCI DEVICE Phase PHASE3 Left Ventricular Dysfunction ClinicalTrials.gov
    Open surgical repair PROCEDURE Phase PHASE3 Abdominal Aortic Aneurysm ClinicalTrials.gov
    QUANTUM LP™ STENT GRAFT SYSTEM DEVICE Phase PHASE3 Abdominal Aortic Aneurysm ClinicalTrials.gov
    Electronic personal health record OTHER Approved Hypertension ClinicalTrials.gov
    Bare metal Bx Velocity™ DEVICE Phase PHASE2 Coronary Artery Disease ClinicalTrials.gov
    Sirolimus coated Bx Velocity™ DEVICE Phase PHASE2 Coronary Artery Disease ClinicalTrials.gov
    Conor Medsystems COSTAR™ stent (30 µg Paclitaxel) DEVICE Phase PHASE3 Treatment of Symptomatic Ischemic Heart Disease ClinicalTrials.gov
    Conor Medsystems COSTAR™ stent (10 µg Paclitaxel) DEVICE Phase PHASE3 Treatment of Symptomatic Ischemic Heart Disease ClinicalTrials.gov
    drug eluting stent DEVICE Phase PHASE4 Peripheral Arterial Diseases ClinicalTrials.gov
    balloon angioplasty DEVICE Phase PHASE4 Peripheral Arterial Diseases ClinicalTrials.gov
    SES DEVICE Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    Cypher stent ™ or Cypher Select ™ DEVICE Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    Uncoated BX VELOCITY Balloon-Expandable Stent DEVICE Phase PHASE3 Coronary Artery Disease ClinicalTrials.gov
    emboli capturing guidewire device combined with stent DEVICE Phase PHASE2 Coronary Artery Disease ClinicalTrials.gov
    4.0 CYPHER Sirolimus-Eluting Coronary Stent DEVICE Phase PHASE3 Coronary Artery Disease ClinicalTrials.gov
    OPTEASE Vena Cava Filter DEVICE Phase PHASE4 Pulmonary Embolism ClinicalTrials.gov
    Sirolimus-eluting Palmaz Genesis peripheral stent DEVICE Phase PHASE2 Renal Artery Stenosis ClinicalTrials.gov
    Brachytherapy PROCEDURE Phase PHASE3 In-Stent Restenosis ClinicalTrials.gov
    Sirolimus-Eluting Bx Velocity® Balloon Expandable Stent DEVICE Phase PHASE3 In-Stent Restenosis ClinicalTrials.gov
    Transfusion of Pathogen Inactivated Platelets stored for 6-7 days DEVICE Phase PHASE3 Thrombocytopenia ClinicalTrials.gov
    Bx SONIC bare metal stent DEVICE Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    Sirolimus-Eluting Bx Velocity Coronary Stent (CypherTM Sirolimus-Eluting Stent) DEVICE Preclinical Coronary Artery Disease ClinicalTrials.gov
    Costar ™ Paclitaxel-Eluting Coronary Stent System DEVICE Phase PHASE3 Coronary Disease ClinicalTrials.gov
    SymBio™ Pimecrolimus/Paclitaxel-Eluting Coronary Stent System DEVICE Phase PHASE3 Coronary Disease ClinicalTrials.gov
    Corio™ Pimecrolimus-Eluting Coronary Stent System DEVICE Phase PHASE3 Coronary Disease ClinicalTrials.gov
    Vascular Closure Device DEVICE Phase PHASE3 Angioplasty, Transluminal, Percutaneous Coronary ClinicalTrials.gov
    Manual Compression OTHER Phase PHASE3 Angioplasty, Transluminal, Percutaneous Coronary ClinicalTrials.gov
    7F Ensure Medical Vascular Closure Device DEVICE Phase PHASE1 Angioplasty, Transluminal, Percutaneous Coronary ClinicalTrials.gov
    Vascular access site closure (7F Ensure) DEVICE Phase PHASE2 Angioplasty, Transluminal, Percutaneous Coronary ClinicalTrials.gov
    TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent DEVICE Phase PHASE3 Coronary Disease ClinicalTrials.gov
    CoStar Paclitaxel Drug Eluting Coronary Stent System DEVICE Phase PHASE3 Coronary Disease ClinicalTrials.gov
    Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System) DEVICE Approved Coronary Atherosclerosis ClinicalTrials.gov
    NEVO™ Sirolimus-eluting Coronary Stent System DEVICE Approved Coronary Atherosclerosis ClinicalTrials.gov
    XIENCE V®/XIENCE PRIME™/PROMUS® Everolimus-eluting Coronary Stent System) DEVICE Phase PHASE3 Atherosclerotic Coronary Artery Disease ClinicalTrials.gov
    Cypher sirolimus eluting coronary stent DEVICE Phase PHASE3 Coronary Occlusions ClinicalTrials.gov
    Immediate coronary stenting PROCEDURE Approved ST-segment Elevation Myocardial Infarction ClinicalTrials.gov
    Deferred coronary stenting PROCEDURE Approved ST-segment Elevation Myocardial Infarction ClinicalTrials.gov
    Insulin, Asp(B28)- DRUG Approved Type 2 Diabetes Mellitus ClinicalTrials.gov
    PaQ® Insulin Delivery Device DEVICE Approved Type 2 Diabetes Mellitus ClinicalTrials.gov
    Placebo & Aspirin DRUG Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    Clopidogrel & Aspirin, Prasugrel & Aspirin DRUG Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    Platelet transfusion PROCEDURE Phase PHASE3 Leukemia ClinicalTrials.gov
    PaQ™ insulin infusion device DEVICE Approved Type 2 Diabetes Mellitus ClinicalTrials.gov
    Percutaneous coronary intervention PROCEDURE Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    CYPHER® Bx VELOCITY® Sirolimus-eluting Stent System DEVICE Approved Coronary Artery Disease ClinicalTrials.gov
    CYPHER® ELITE™ Sirolimus-Eluting Stent System DEVICE Approved Coronary Artery Disease ClinicalTrials.gov
    sirolimus-eluting stent, zotarolimus-eluting stent DEVICE Phase PHASE3 Coronary Artery Disease ClinicalTrials.gov
    Conventional, untreated Red Blood Cells (RBCs) BIOLOGICAL Phase PHASE2 Focus: Assess Post Infusion Viability of S303 RBCs ClinicalTrials.gov
    S303 Red Blood Cells (RBCs) BIOLOGICAL Phase PHASE2 Focus: Assess Post Infusion Viability of S303 RBCs ClinicalTrials.gov
    Conventional, untreated red blood cells (RBCs) - Control BIOLOGICAL Phase PHASE3 Focus:Use of S303 RBCs in Patients With Acute Anemia ClinicalTrials.gov
    S-303 Red Blood Cells (RBCs) - Test BIOLOGICAL Phase PHASE3 Focus:Use of S303 RBCs in Patients With Acute Anemia ClinicalTrials.gov
    two stent DEVICE Phase PHASE3 Coronary Disease ClinicalTrials.gov
    single stent DEVICE Phase PHASE3 Coronary Disease ClinicalTrials.gov
    Angio guidance arm DEVICE Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    3D OFDI guidance arm DEVICE Phase PHASE4 Coronary Artery Disease ClinicalTrials.gov
    S.M.A.R.T. ® Stent DEVICE Approved Superficial Femoral Artery Disease ClinicalTrials.gov
    Angioseal closure device DEVICE Approved Coronary Disease ClinicalTrials.gov
    Exoseal closure device DEVICE Approved Coronary Disease ClinicalTrials.gov
    Autologous apheresis Conventional untreated Platelet Components BIOLOGICAL Phase PHASE2 Healthy ClinicalTrials.gov
    Conventional, untreated Red Blood Cells BIOLOGICAL Phase PHASE3 Thalassemia Major ClinicalTrials.gov
    S-303 Treated Red Blood Cells (RBCs) BIOLOGICAL Phase PHASE3 Thalassemia Major ClinicalTrials.gov
    FlexStent® Femoropopliteal Self Expanding Stent System DEVICE Approved Peripheral Artery Disease ClinicalTrials.gov
    INTERCEPT treated platelets BIOLOGICAL Phase PHASE2 Healthy ClinicalTrials.gov
    Standard of Care DEVICE Approved Anemia ClinicalTrials.gov
    INTERCEPT DEVICE Approved Anemia ClinicalTrials.gov
    Endovascular AAA repair DEVICE Preclinical Abdominal Aortic Aneurysm ClinicalTrials.gov
    Red cell survival in INTERCEPT treated red cells DEVICE Approved Red Cell Survival in Healthy Volunteers ClinicalTrials.gov
    Biofreedom drug-coated stent DEVICE Preclinical Coronary Artery Disease Aggravated ClinicalTrials.gov
    INTERCEPT Plasma BIOLOGICAL Phase PHASE1 Acute Ebola Virus Disease ClinicalTrials.gov
    INCRAFT DEVICE Preclinical Abdominal Aortic Aneurysms ClinicalTrials.gov
    Nitrate DRUG Approved Vasodilation ClinicalTrials.gov
    macitentan 10 mg DRUG Phase PHASE3 Chronic Thromboembolic Pulmonary Hypertension (CTEPH) ClinicalTrials.gov
    IVC Filter DEVICE Preclinical Pulmonary Embolism ClinicalTrials.gov
    Adroit Guiding Catheter, Cordis Transradial Access Devices, Cordis Diagnostic Catheters, Cordis Guidewires DEVICE Preclinical Coronary Artery Disease ClinicalTrials.gov
    Taxus Liberte, Boston Scientific DEVICE Phase PHASE4 Myocardial Infarction ClinicalTrials.gov
    Cypher, Cordis DEVICE Phase PHASE4 Myocardial Infarction ClinicalTrials.gov
    Endeavor, Medtronic DEVICE Phase PHASE4 Myocardial Infarction ClinicalTrials.gov
    Cordis AAA stent graft system "INCRAFT TM" DEVICE Approved Abdominal Aortic Aneurysms ClinicalTrials.gov
    Amustaline/GSH pathogen reduction technology DEVICE Approved Safety Issues ClinicalTrials.gov
    Endovascular AAA repair with InCraft® DEVICE Approved Abdominal Aortic Aneurysm ClinicalTrials.gov
    Endovascular abdominal aortic aneurysm repair DEVICE Preclinical Abdominal Aortic Aneurysms ClinicalTrials.gov
    Cern Device DEVICE Approved Bacterial Vaginosis ClinicalTrials.gov
    INTERCEPT Blood System DEVICE Phase PHASE1 Sickle Cell Disease ClinicalTrials.gov
    Biotin Labeled Red Blood Cells DRUG Phase PHASE1 Sickle Cell Disease ClinicalTrials.gov
    Control DEVICE Phase PHASE3 Anemia ClinicalTrials.gov
    INTERCEPT RBCs DEVICE Phase PHASE2 Transfusion Reaction, Hemolytic ClinicalTrials.gov
    PALMAZ MULLINS XD™ Pulmonary Stent DEVICE Preclinical Pulmonary Artery Stenosis ClinicalTrials.gov
    INTERCEPT Blood System for Platelets with LED Illuminator DEVICE Phase PHASE2 Healthy Subjects ClinicalTrials.gov
    SELUTION SLR™ DEB DEVICE Approved Coronary Restenosis ClinicalTrials.gov
    Pathogen reduced red blood cells DEVICE Phase PHASE2 Sickle Cell Disease ClinicalTrials.gov
    SABERX RADIANZ™ PTA Balloon Catheter DEVICE Approved Peripheral Arterial Disease ClinicalTrials.gov
    BRITE TIP RADIANZ™ Guiding Sheath DEVICE Approved Peripheral Arterial Disease ClinicalTrials.gov
    S.M.A.R.T. RADIANZ™ Vascular Stent System DEVICE Approved Peripheral Arterial Disease ClinicalTrials.gov
    OrthoCor Active System DEVICE Approved Pain ClinicalTrials.gov
    MYNX CONTROL™ Venous Vascular Closure Device 6F-12F DEVICE Approved Venous Vascular Closure ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Cerus Corporation
    • Ticker Symbol: CERS

Search

News categories